Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARTEMIS: A Prospective Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

NCT05380557 is registered in ClinicalTrials.gov with Invitae Corporation as lead sponsor.

NCT NCT05380557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARTEMIS: A Prospective Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing
Lead sponsor
Invitae Corporation
Phase
Observational
Overall status
Terminated
Start date
August 23, 2021
Completion date
September 6, 2022
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma, pancreatic cancer, resectable pancreatic cancer